M&A Deal Summary |
|
---|---|
Date | 2021-11-02 |
Target | Guidemark Health |
Sector | Marketing |
Buyer(s) | Lumanity |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, the company transforms data and information into real-world insights and evidence that powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action. Lumanity was formed in 2020 and is based in Bethesda, Maryland.
DEAL STATS | # |
---|---|
Overall | 3 of 8 |
Sector (Marketing) | 1 of 2 |
Type (Add-on Acquisition) | 1 of 5 |
State (New Jersey) | 1 of 2 |
Country (United States) | 1 of 5 |
Year (2021) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-08-11 |
Cello Health
London, United Kingdom Cello Health is a global healthcare-focused advisory firm comprised of a set of leading scientific, commercial advisory, and digital delivery capabilities. Cello Health currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices, and other key non-healthcare clients. Cello Health is based in London, United Kingdom. |
Buy | £182M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-12-08 |
Cyan Health
Montclair, New Jersey, United States Cyan Health is a strategic payer marketing agency focused on guiding clients to successful market access for their products. Cyan identifies the critical challenges to access, develops the strategy needed for success, creates compelling communications for payers, and establishes how best to implement these in the field with payer customers. Cyan Health was founded in 2014 and is based in Montclair, New Jersey. |
Buy | - |